Form 4: RxSight COO Ilya Goldshleger Acquires 92,200 Stock Options

RxSight's Chief Operating Officer, Ilya Goldshleger, acquired 92,200 stock options on March 4, 2024, according to a Form 4 filing with the SEC.

Summary

• Ilya Goldshleger, the Chief Operating Officer of RxSight, Inc. (RXST), acquired 92,200 stock options on March 4, 2024.
• The options have an exercise price of $56.07.
• The options vest monthly over a four-year period, commencing on March 4, 2024, subject to continued service with the company.
• The options expire on March 3, 2034.

Sentiment

Score: 6

Explanation: The document itself is neutral, simply reporting a stock option grant. The sentiment is slightly positive as it indicates the company is incentivizing its executives.

Positives

• The acquisition of stock options by a key executive can be seen as a positive sign, indicating confidence in the company's future performance.

Industry Context

This is a standard practice for companies to incentivize and retain key executives through equity compensation.

Comparison to Industry Standards

• Stock option grants are a common form of executive compensation in the technology and healthcare industries.
• Vesting schedules, such as the monthly vesting over four years described in the document, are typical for stock option grants.
• The size of the grant should be compared to similar grants at peer companies to determine if it is above or below industry standards.

Key Dates